Kevin Reeder

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

BM-T Beteiligungsmanagement Thüringen GmbH (BMT) is the investment arm and a wholly-owned subsidiary of Thüringen Aufbaubank, which in turn is part of Landesbank Hessen-Thüringen Girozentrale, also known as HELABA-Hessische Landesbank. HELABA is a regional bank in Länder Hessen and Thüringen, controlled but the Government of Germany. BMT was established in 2003 and is headquartered in Erfurt, the capital of Land Thüringen in central Germany. The firm invests on behalf of the German government, and is backed by Land Thüringen. They originally received capital from TBG-Technologie Beteiligungs GmbH as well. TBG is a Bonn-based private equity entity part of the government-controlled KfW Bankengruppe. BMT manages venture capital and private equity funds.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

BM-T Beteiligungsmanagement Thüringen GmbH (BMT) is the investment arm and a wholly-owned subsidiary of Thüringen Aufbaubank, which in turn is part of Landesbank Hessen-Thüringen Girozentrale, also known as HELABA-Hessische Landesbank. HELABA is a regional bank in Länder Hessen and Thüringen, controlled but the Government of Germany. BMT was established in 2003 and is headquartered in Erfurt, the capital of Land Thüringen in central Germany. The firm invests on behalf of the German government, and is backed by Land Thüringen. They originally received capital from TBG-Technologie Beteiligungs GmbH as well. TBG is a Bonn-based private equity entity part of the government-controlled KfW Bankengruppe. BMT manages venture capital and private equity funds.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

BM-T Beteiligungsmanagement Thüringen GmbH (BMT) is the investment arm and a wholly-owned subsidiary of Thüringen Aufbaubank, which in turn is part of Landesbank Hessen-Thüringen Girozentrale, also known as HELABA-Hessische Landesbank. HELABA is a regional bank in Länder Hessen and Thüringen, controlled but the Government of Germany. BMT was established in 2003 and is headquartered in Erfurt, the capital of Land Thüringen in central Germany. The firm invests on behalf of the German government, and is backed by Land Thüringen. They originally received capital from TBG-Technologie Beteiligungs GmbH as well. TBG is a Bonn-based private equity entity part of the government-controlled KfW Bankengruppe. BMT manages venture capital and private equity funds.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

BM-T Beteiligungsmanagement Thüringen GmbH (BMT) is the investment arm and a wholly-owned subsidiary of Thüringen Aufbaubank, which in turn is part of Landesbank Hessen-Thüringen Girozentrale, also known as HELABA-Hessische Landesbank. HELABA is a regional bank in Länder Hessen and Thüringen, controlled but the Government of Germany. BMT was established in 2003 and is headquartered in Erfurt, the capital of Land Thüringen in central Germany. The firm invests on behalf of the German government, and is backed by Land Thüringen. They originally received capital from TBG-Technologie Beteiligungs GmbH as well. TBG is a Bonn-based private equity entity part of the government-controlled KfW Bankengruppe. BMT manages venture capital and private equity funds.

BM-T Beteiligungsmanagement Thüringen GmbH (BMT) is the investment arm and a wholly-owned subsidiary of Thüringen Aufbaubank, which in turn is part of Landesbank Hessen-Thüringen Girozentrale, also known as HELABA-Hessische Landesbank. HELABA is a regional bank in Länder Hessen and Thüringen, controlled but the Government of Germany. BMT was established in 2003 and is headquartered in Erfurt, the capital of Land Thüringen in central Germany. The firm invests on behalf of the German government, and is backed by Land Thüringen. They originally received capital from TBG-Technologie Beteiligungs GmbH as well. TBG is a Bonn-based private equity entity part of the government-controlled KfW Bankengruppe. BMT manages venture capital and private equity funds.

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

BM-T Beteiligungsmanagement Thüringen GmbH (BMT) is the investment arm and a wholly-owned subsidiary of Thüringen Aufbaubank, which in turn is part of Landesbank Hessen-Thüringen Girozentrale, also known as HELABA-Hessische Landesbank. HELABA is a regional bank in Länder Hessen and Thüringen, controlled but the Government of Germany. BMT was established in 2003 and is headquartered in Erfurt, the capital of Land Thüringen in central Germany. The firm invests on behalf of the German government, and is backed by Land Thüringen. They originally received capital from TBG-Technologie Beteiligungs GmbH as well. TBG is a Bonn-based private equity entity part of the government-controlled KfW Bankengruppe. BMT manages venture capital and private equity funds.